Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |